Two Federal Courts Reject Pfizer’s Federal Preemption Argument in cases involving Zoloft

Two Federal Courts Reject Pfizer’s Federal Preemption Argument in cases involving Zoloft Fri, 01 Apr 2005 With assistance from Daniel Troy as chief counsel of the FDA, Pfizer argued that state courts have no right to decide that a drug manufacturer can be held liable for not disclosing severe –…

Minnesota Attorney General Supports Widow in Zoloft Suicide Case

Minnesota Attorney General Supports Widow in Zoloft Suicide Case Tue, 22 Mar 2005 A press release from the law firm, Baum Hedlund announces that Minnesota’s State Attorney General filed a legal brief refuting Pfizer’s claim that “it should be immune from liability for failing to warn about dangerous side effects…

Three Senior NIH Researchers in COI Controversy Are Leaving – LAT

Three Senior NIH Researchers in COI Controversy Are Leaving – LAT Thu, 10 Mar 2005 The Los Angeles Times reports that three senior NIH researchers whose paid consultancies are central to the heated controversy over professional / financial conflicts of interest are leaving. The revelations that sparked the controversy –…

US Marshals Seize Millions of Defective Paxil & Avandamet pills – NYT

US Marshals Seize Millions of Defective Paxil & Avandamet pills_NYT Mon, 7 Mar 2005 The FDA and federal marshals yanked millions of tablets of the antidepressant, Paxil CR (Seroxat, controlled release) and the diabetes drug, Avandamet, off the market because they are defective. The Paxil pills split during manufacturing, and…

NIH Scientists Gripe At Ethics Rule: NO Stocks in Pharmaceutical Companies – LAT / WSJ

NIH Scientists Gripe At Ethics Rule: NO Stocks in Pharmaceutical Companies – LAT / WSJ Sat, 5 Mar 2005 A group of dissident NIH scientists represented by an 18 member executive committee, are gripping about new rules prohibiting them from accepting fees for outside activities. Conflict of interest rules apply…

Pfizer Marketing Scheme Stirs Concern/ Corporate Responsibility Movement Puts PhRMA on Notice

Pfizer Marketing Scheme Stirs Concern_NYT / Corporate Responsibility Movement Puts PhRMA on Notice_ ICCR Mon, 7 Mar 2005 The New York Times reports that Pfizer is planning to lock up the market for heart treaments by bundling its new drug (toretrapib, which is still in experimental stage of development) to…

FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT

FDA Panel Poses Pointed Questions to Drug Makers Over Risks of Painkillers – NYT Thu, 17 Feb 200 A three day public advisory panel hearing which is overflowing with attendees from around the world, is an investigation of the conduct of pharmaceutical company giants and the FDA. The hearing began…